Pharmaceutical Methods
Publishing Quality Research & Reviews
Pharmaceutical Methods
Publishing Quality Research & Reviews
Author(s): Bhupendra Shrestha, Nihar Ranjan Bhuyan, and Barij Nayan Sinha
Aim: Stability indicating ultra-high performance liquid chromatography (UHPLC) method was developed and validated for the determination of cefepime (CFPM) and tazobactam (TZB) in injectable dosage form. Materials and Methods: Separation was performed in a Dionex Ultimate 3000 UHPLC system equipped with chromeleon software using Acclaim 120 C18 (250 × 4.6 mm, 5 μm particle size) column with mobile phase (pH 6.0) containing methanol and sodium acetate buffer in the ratio of 11:89 v/v with a flow rate of 1.8 mL/min and detection wavelength of 220 nm. Stress studies were performed using HCl, NaOH, H2O2, and ultraviolet radiation. Results: The method was found to be linear in the concentration range of 50-350 μg/ml (R2 = 0.998) and 6.25-43.75 μg/ml (R2 = 0.998) with the regression equation y = 11068 x + 115231 and y = 8317.1x – 9869.7 for CFPM and TZB, respectively. The percentage of relative standard deviation (%RSD) of 0.63 and 1.39 for intra-day and 0.64 and 0.54 for inter-day precision, respectively for CFPM and TZB suggest the precision of the method as all these values are <2%. It was found from the stress studies that both the drugs are very susceptible to alkaline condition. The method has shown good, consistent recoveries for CFPM (100.6-102.0%) with mean RSD of 0.73% and TZB (98.4-100.6%) with mean RSD of 1.14%, which indicates the method is sufficiently accurate. Conclusion: The method was found to be accurate, precise, specific, robust, linear, and stability indicating for the determination of CFPM and TZB in injectable dosage form.
Pharmaceutical Methods received 3403 citations as per google scholar report
